Immunosuppressant (IPT)

"... for laboratories that quantify immunosuppressant drugs in blood and plasma"

 

Immunosuppressant drugs are a class of drugs that suppress, or reduce, the strength of the body’s immune system. In addition to being used to prevent organ rejection, they are often used to treat autoimmune disorders such as lupus, psoriasis, and rheumatoid arthritis. Regular blood tests are essential for monitoring therapeutic levels and whether dosage changes are needed. To make these informed decisions successfully, laboratories need to demonstrate that drug measurements are reliable, reproducible, and accurate. The Immunosuppressants (IPT) proficiency testing programme, provides independent performance assessment for laboratories quantifying immunosuppressant drugs in blood and plasma. 

The operation of the Immunosuppressants proficiency testing scheme is supported by an Advisory Group consisting of members of professional bodies, scheme participants, and others experienced in the field. The scheme reports on the performance of UK participants (who have clinical responsibilities) to the National Quality Assurance Advisory Panels for Chemical Pathology.